AUS
NZ
UK
CA
USA
IND
Healthcare
All Ordinaries Healthcare Stocks US Market Expansion Focus
April 14, 2026 12:10 PM AEST| By SamHealthcare sector activity highlights milestone payments and international expansion, reflecting continued commercial progress in diagnostic technology within the All Ordinaries index.
How Orthocell Limited (ASX:OCC) Fits in ASX 300 Healthcare Sector Trends
April 14, 2026 11:30 AM AEST| By SamOrthocell prepares quarterly update and investor webinar, reflecting healthcare sector activity and biotechnology development within Australian equity markets.
ASX 200 Healthcare Stock (ASX:TLX): How Telix’s Regeneron Deal and FDA Progress Are Reshaping Its Growth Narrative
April 14, 2026 10:51 AM AEST| By SamTelix Pharmaceuticals gains momentum after a Regeneron partnership and FDA milestone, strengthening its transition toward a multi-product oncology platform, though execution risks and reliance on imaging revenues remain key considerations.
Telix (ASX:TLX) Signals Fresh Growth Trajectory Amid Expanding Footprint
April 13, 2026 03:36 PM AEST| By Team Kalkine MediaTelix Pharmaceuticals advances its oncology strategy through a major collaboration and regulatory milestone, strengthening its radiopharmaceutical platform and expanding its presence beyond core imaging markets.
Is Monash IVF Near a Deal as Takeover Pressure Builds?
April 13, 2026 03:29 PM AEST| By SamMonash IVF reviews a revised takeover proposal as investor interest grows, highlighting valuation debates, sector demand trends, and strategic decisions shaping the company’s future.
Small Move, Big Signal? Syntara’s ASX Update Explained
April 13, 2026 10:53 AM AEST| By SamSyntara has applied to list new shares on the ASX, reflecting routine capital management activity that slightly expands its equity base while improving liquidity and maintaining transparency.
Breakthrough Tech Buzz: Is This ASX Small Cap Turning Heads?
April 13, 2026 10:50 AM AEST| By SamEBR Systems is gaining attention as its cardiac technology sees growing commercial use and clinical progress, highlighting its role in advancing minimally invasive healthcare solutions within the Australian market.
Aroa Biosurgery Drives Momentum Beyond ASX 200 Buzz
April 10, 2026 10:35 PM AEST| By Team Kalkine MediaAroa Biosurgery strengthens its growth pathway through new share quotation, supporting innovation, expanding market reach, and aligning with broader trends shaping Australia’s healthcare and equity environment.
Is Sonic Healthcare Facing a Valuation Reset at Lows?
April 10, 2026 06:43 PM AEST| By SamSonic Healthcare’s valuation debate deepens as shares hover near long-term lows, with investors weighing sector challenges against evolving healthcare demand and future growth drivers.
Healthcare Momentum Builds as ASX 200 Focus Turns to Strength
April 10, 2026 04:45 PM AEST| By Team Kalkine MediaA healthcare stock on the ASX gains attention as broader markets face pressure, highlighting sector resilience, operational developments, and investor focus shifts.
Telix Pharmaceuticals ASX 200 FDA Drug Progress Focus
April 10, 2026 04:21 PM AEST| By SamTelix Pharmaceuticals progresses regulatory review for its imaging drug, reflecting continued activity within the healthcare and biotechnology sector in Australia.
Arovella ASX Developments Reflect Activity With Healthcare Segment
April 10, 2026 03:46 PM AEST| By SamArovella Therapeutics advances share quotation, reflecting continued activity within the biotech sector and structured participation in the ASX stock market.
ASX 200 Healthcare Stocks: Is Value Emerging After Sell-Off?
April 10, 2026 11:06 AM AEST| By SamASX healthcare stocks face pressure, but emerging value opportunities and companies like Telix highlight long-term growth potential within the ASX 200 sector.
ASX Biotech Stock CHM Crashes: Panic or Opportunity?
April 10, 2026 10:39 AM AEST| By SamChimeric Therapeutics faces sharp decline amid heavy selling, highlighting volatility in ASX biotech small-cap stocks and broader sector pressure.
ASX Healthcare Stock CGS Adds Shares in Quiet Move
April 10, 2026 10:09 AM AEST| By SamCogstate lists additional shares on the ASX following securities conversion, reflecting routine capital management within the healthcare technology sector.
ASX Healthcare Stock Jumps on Breakthrough Momentum
April 10, 2026 09:56 AM AEST| By SamEBR Systems gains traction as its wireless cardiac technology expands clinical use, strengthens hospital networks, and advances commercial rollout in Australia’s healthcare sector.
ASX Healthcare Stocks Rebound Story: Hidden Value Emerging
April 10, 2026 09:49 AM AEST| By SamASX healthcare stocks have faced recent pressure, but companies like Telix, Mayne Pharma and EBR Systems are drawing attention as innovation and commercial progress continue to shape sector dynamics.
ASX All Ordinaries Healthcare Update as EBR Restructures
April 10, 2026 09:45 AM AEST| By SamEBR Systems completes reverse stock split and prepares for trading resumption, reflecting corporate restructuring within the ASX All Ordinaries healthcare sector.
Is Mesoblast’s Latest FDA Nod a Turning Point or a Pause?
April 09, 2026 08:15 PM AEST| By SamMesoblast gains attention after FDA clearance for Ryoncil trial, sparking debate around valuation, pipeline strength, and future growth in the biotech sector.
All Ordinaries: SHG (ASX:SHG) Shares Update on Capital Move
April 09, 2026 07:20 PM AEST| By SamSingular Health expands share capital through new quotation, reflecting capital management activity within the technology and healthcare sector across the All Ordinaries index.
Advertise your brand on Kalkine Media